Ambroxol for the prevention of acute upper respiratory disease

K. Nobata, H. Asanoi (Imizu, Japan)

Source: Annual Congress 2009 - Treatment of airways disease
Session: Treatment of airways disease
Session type: Thematic Poster Session
Number: 2089
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Nobata, H. Asanoi (Imizu, Japan). Ambroxol for the prevention of acute upper respiratory disease. Eur Respir J 2009; 34: Suppl. 53, 2089

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Early intervention with non-invasive respiratory therapies in mild acute respiratory distress syndrome secondary to COVID-19
Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19
Year: 2021


The treatment of acute respiratory viral infections in a patients with a chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012


Viral upper respiratory infection and acute asthma exacerbation
Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection
Year: 2009

Managing respiratory failure and symptom control in acute and chronic settings
Source: Annual Congress 2008 - PG19 - Ventilatory management and cough enhancement in patients with neuromuscular disease
Year: 2008



Non-invasive respiratory strategies in acute respiratory failure
Source: International Congress 2018 – State of the art session: Respiratory critical care
Year: 2018


Acute and chronic respiratory infections
Source: ERS Course 2018 - Summer school of paediatric respiratory medicine
Year: 2018

Acute and chronic respiratory infections
Source: ERS Skills Course 2016
Year: 2016

Acute and chronic respiratory infections
Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine
Year: 2017

High-flow nasal therapy in acute and chronic respiratory failure
Source: International Congress 2018 – Therapeutic breakthroughs Year in Review
Year: 2018


Management of acute exacerbation of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=387
Year: 2006

Management of lower respiratory tract infections by French general practitioners: the AIR II study
Source: Eur Respir J 2002; 19: 314-319
Year: 2002



Obstructive pulmonary disease with acute respiratory failure
Source: ISSN=1025-448x, ISBN=1-904097-17-0, page=11
Year: 2001

Acute effects of early mobility and respiratory therapy in hospitalised patients with chronic heart failure
Source: Annual Congress 2009 - Respiratory physiotherapy assessment
Year: 2009


Pathogenesis of acute microvascular lung injury and the acute respiratory distress syndrome
Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=22
Year: 2002

The development of chronic respiratory failure in patients with different disabling respiratory disorders
Source: Annual Congress 2009 - COPD, chronic respiratory failure and rehabilitation
Year: 2009


Evaluation of nasal optiflow device in management of COPD patients in acute exacerbations
Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning
Year: 2015

Treatment and prevention of acute respiratory viral infections in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Viral infections
Year: 2013

Occurrence of obstruction of respiratory tracts among acute respiratory diseases in children hospital
Source: Annual Congress 2012 - Paediatric respiratory epidemiology. Wheeze: where, how and why?
Year: 2012


Asthma and acute infections of upper respiratory tract in children
Source: Eur Respir J 2006; 28: Suppl. 50, 253s
Year: 2006